Compare EQ & RGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQ | RGT |
|---|---|---|
| Founded | 2017 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.4M | 94.4M |
| IPO Year | 2018 | N/A |
| Metric | EQ | RGT |
|---|---|---|
| Price | $1.52 | $14.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.56 | N/A |
| AVG Volume (30 Days) | ★ 344.2K | 18.7K |
| Earning Date | 11-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | ★ $41,095,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.16 | $12.01 |
| 52 Week High | $6.20 | $15.79 |
| Indicator | EQ | RGT |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 64.85 |
| Support Level | $1.30 | $14.02 |
| Resistance Level | $2.53 | $15.65 |
| Average True Range (ATR) | 0.13 | 0.28 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 79.55 | 100.00 |
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Royce Global Value Trust Inc is a diversified closed-end investment company. The Fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples and energy. Geographically, it has presence in the United Kingdom, Japan, the United States, Canada, France, Hong Kong and Germany.